|
1
|
Siegel RL, Giaquinto AN and Jemal A:
Cancer statistics, 2024. CA Cancer J Clin. 74:12–49.
2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sonkin D, Thomas A and Teicher BA: Cancer
treatments: Past, present, and future. Cancer Genet. 286-287:18–24.
2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hoang DM, Pham PT, Bach TQ, Ngo ATL,
Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, et
al: Stem cell-based therapy for human diseases. Signal Transduct
Target Ther. 7(272)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fus-Kujawa A, Mendrek B, Trybus A,
Bajdak-Rusinek K, Stepien KL and Sieron AL: Potential of induced
pluripotent stem cells for use in gene therapy: History, molecular
bases, and medical perspectives. Biomolecules.
11(699)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shojaei S, Hashemi SM, Ghanbarian H,
Salehi M and Mohammadi-Yeganeh S: Effect of mesenchymal stem
cells-derived exosomes on tumor microenvironment: Tumor progression
versus tumor suppression. J Cell Physiol. 234:3394–3409.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li X, Peng B, Zhu X, Wang P, Xiong Y, Liu
H, Sun K, Wang H, Ou L, Wu Z, et al: Changes in related circular
RNAs following ERβ knockdown and the relationship to rBMSC
osteogenesis. Biochem Biophys Res Commun. 493:100–107.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fu X, Liu G, Halim A, Ju Y, Luo Q and Song
AG: Mesenchymal stem cell migration and tissue repair. Cells.
8(784)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Olmedo-Moreno L, Aguilera Y,
Baliña-Sánchez C, Martín-Montalvo A and Capilla-González V:
Heterogeneity of in vitro expanded mesenchymal stromal cells and
strategies to improve their therapeutic actions. Pharmaceutics.
14(1112)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vizoso FJ, Eiro N, Cid S, Schneider J and
Perez-Fernandez R: Mesenchymal stem cell secretome: Toward
cell-free therapeutic strategies in regenerative medicine. Int J
Mol Sci. 18(1852)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang W and Han ZC: Heterogeneity of human
mesenchymal stromal/stem cells. Adv Exp Med Biol. 1123:165–177.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cerneckis J, Cai H and Shi Y: Induced
pluripotent stem cells (iPSCs): Molecular mechanisms of induction
and applications. Signal Transduct Target Ther.
9(112)2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bindhya S, Sidhanth C, Shabna A,
Krishnapriya S, Garg M and Ganesan TS: Induced pluripotent stem
cells: A new strategy to model human cancer. Int J Biochem Cell
Biol. 107:62–68. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhou X, Liu J, Wu F, Mao J, Wang Y, Zhu J,
Hong K, Xie H, Li B, Qiu X, et al: The application potential of
iMSCs and iMSC-EVs in diseases. Front Bioeng Biotechnol.
12(1434465)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sabapathy V and Kumar S: hiPSC-derived
iMSCs: NextGen MSCs as an advanced therapeutically active cell
resource for regenerative medicine. J Cell Mol Med. 20:1571–1588.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wruck W, Graffmann N, Spitzhorn LS and
Adjaye J: Human induced pluripotent stem cell-derived mesenchymal
stem cells acquire rejuvenation and reduced heterogeneity. Front
Cell Dev Biol. 9(717772)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kopen GC, Prockop DJ and Phinney DG:
Marrow stromal cells migrate throughout forebrain and cerebellum,
and they differentiate into astrocytes after injection into
neonatal mouse brains. Proc Natl Acad Sci USA. 96:10711–10716.
1999.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bittira B, Shum-Tim D, Al-Khaldi A and
Chiu RC: Mobilization and homing of bone marrow stromal cells in
myocardial infarction. Eur J Cardiothorac Surg. 24:393–398.
2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pittenger MF and Martin BJ: Mesenchymal
stem cells and their potential as cardiac therapeutics. Cir Res.
95:9–20. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Phinney DG and Pittenger MF: Concise
review: MSC-derived exosomes for cell-free therapy. Stem Cells.
35:851–858. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lin H, Chen H, Zhao X, Chen Z, Zhang P,
Tian Y, Wang Y, Ding T, Wang L and Shen Y: Advances in mesenchymal
stem cell conditioned medium-mediated periodontal tissue
regeneration. J Transl Med. 19(456)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kumar MA, Baba SK, Sadida HQ, Marzooqi SA,
Jerobin J, Altemani FH, Algehainy N, Alanazi MA, Abou-Samra AB,
Kumar R, et al: Extracellular vesicles as tools and targets in
therapy for diseases. Signal Transduct Target Ther.
9(27)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bogatcheva NV and Coleman ME: Conditioned
medium of mesenchymal stromal cells: A new class of therapeutics.
Biochemistry (Mosc). 84:1375–1389. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cheshomi H and Matin MM: Exosomes and
their importance in metastasis, diagnosis, and therapy of
colorectal cancer. J Cell Biochem. 120:2671–2686. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fuloria S, Subramaniyan V, Dahiya R,
Dahiya S, Sudhakar K, Kumari U, Sathasivam K, Meenakshi DU, Wu YS,
Sekar M, et al: Mesenchymal stem cell-derived extracellular
vesicles: Regenerative potential and challenges. Biology (Basel).
10(172)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Brossa A, Fonsato V, Grange C, Tritta S,
Tapparo M, Calvetti R, Cedrino M, Fallo S, Gontero P, Camussi G and
Bussolati B: Extracellular vesicles from human liver stem cells
inhibit renal cancer stem cell-derived tumor growth in vitro and in
vivo. Int J Cancer. 147:1694–1706. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Simeone P, Bologna G, Lanuti P,
Pierdomenico L, Guagnano MT, Pieragostino D, Del Boccio P, Vergara
D, Marchisio M, Miscia S and Mariani-Costantini R: Extracellular
vesicles as signaling mediators and disease biomarkers across
biological barriers. Int J Mol Sci. 21(2514)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Abels ER and Breakefield XO: Introduction
to extracellular vesicles: Biogenesis, RNA cargo selection,
content, release, and uptake. Cell Mol Neurobiol. 36:301–312.
2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jin Y, Ma L, Zhang W, Yang W, Feng Q and
Wang H: Extracellular signals regulate the biogenesis of
extracellular vesicles. Biol Res. 55(35)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vinaiphat A and Sze SK: Advances in
extracellular vesicles analysis. Adv Clin Chem. 97:73–116.
2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Greening DW and Simpson RJ: Understanding
extracellular vesicle diversity-current status. Expert Rev
Proteomics. 15:887–910. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
van Niel G, D'Angelo G and Raposo G:
Shedding light on the cell biology of extracellular vesicles. Nat
Rev Mol Cell Biol. 19:213–228. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Doyle LM and Wang MZ: Overview of
extracellular vesicles, their origin, composition, purpose, and
methods for exosome isolation and analysis. Cells.
8(727)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Del Fattore A, Luciano R, Saracino R,
Battafarano G, Rizzo C, Pascucci L, Alessandri G, Pessina A,
Perrotta A, Fierabracci A and Muraca M: Differential effects of
extracellular vesicles secreted by mesenchymal stem cells from
different sources on glioblastoma cells. Expert Opin Biol Ther.
15:495–504. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Berumen Sánchez G, Bunn KE, Pua HH and
Rafat M: Extracellular vesicles: Mediators of intercellular
communication in tissue injury and disease. Cell Commun Signal.
19(104)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Skotland T, Sagini K, Sandvig K and
Llorente A: An emerging focus on lipids in extracellular vesicles.
Adv Drug Deliv Rev. 159:308–321. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Muralikumar M, Manoj Jain S, Ganesan H,
Duttaroy AK, Pathak S and Banerjee A: Current understanding of the
mesenchymal stem cell-derived exosomes in cancer and aging.
Biotechnol Rep (Amst). 31(e00658)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hu Y, Li X, Zhang Q, Gu Z, Luo Y, Guo J,
Wang X, Jing Y, Chen X and Su J: Exosome-guided bone targeted
delivery of Antagomir-188 as an anabolic therapy for bone loss.
Bioact Mater. 6:2905–2913. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Guo H and Huang X: Engineered exosomes for
future gene-editing therapy. Biomater Transl. 3:240–242.
2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liu H, Song P, Zhang H, Zhou F, Ji N, Wang
M, Zhou G, Han R, Liu X, Weng W, et al: Synthetic biology-based
bacterial extracellular vesicles displaying BMP-2 and CXCR4 to
ameliorate osteoporosis. J Extracell Vesicles.
13(e12429)2024.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhou Y, Zhou W, Chen X, Wang Q, Li C, Chen
Q, Zhang Y, Lu Y, Ding X and Jiang C: Bone marrow mesenchymal stem
cells-derived exosomes for penetrating and targeted chemotherapy of
pancreatic cancer. Acta Pharm Sin B. 10:1563–1575. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lin Z, Wu Y, Xu Y, Li G, Li Z and Liu T:
Mesenchymal stem cell-derived exosomes in cancer therapy
resistance: Recent advances and therapeutic potential. Mol Cancer.
21(179)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zakiyah N, Wanandi SI, Antarianto RD,
Syahrani RA and Arumsari S: Mesenchymal stem cell-derived
extracellular vesicles increase human MCF7 breast cancer cell
proliferation associated with OCT4 expression and ALDH activity.
Asian Pac J Cancer Prev. 24:2781–2789. 2023.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wang G, Ji X, Li P and Wang W: Human bone
marrow mesenchymal stem cell-derived exosomes containing
microRNA-425 promote migration, invasion and lung metastasis by
down-regulating CPEB1. Regen Ther. 20:107–116. 2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhao Q, Hai B, Kelly J, Wu S and Liu F:
Extracellular vesicle mimics made from iPS cell-derived mesenchymal
stem cells improve the treatment of metastatic prostate cancer.
Stem Cell Res Ther. 12(29)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Liu H, Dilger JP and Lin J: Lidocaine
suppresses viability and migration of human breast cancer cells:
TRPM7 as a target for some breast cancer cell lines. Cancers
(Basel). 13(234)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Li R, Xiao C, Liu H, Huang Y, Dilger JP
and Lin J: Effects of local anesthetics on breast cancer cell
viability and migration. BMC Cancer. 18(666)2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Santucci KL, Snyder KK, Van Buskirk RG,
Baust JG and Baust JM: Investigation of lung cancer cell response
to cryoablation and adjunctive gemcitabine-based cryo-chemotherapy
using the A549 cell line. Biomedicines. 12(1239)2024.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Li J, Zhong X, Zhao Y, Shen J, Xiao Z and
Pilapong C: Acacetin inhibited non-small-cell lung cancer (NSCLC)
cell growth via upregulating miR-34a in vitro and in vivo. Sci Rep.
14(2348)2024.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Huang PH, Duan XB, Tang ZZ, Zou ZX, Song
WM, Gao G, Li D, Nie FQ, Yan X, Fu YX, et al: Betulinaldehyde
exhibits effective anti-tumor effects in A549 cells by regulating
intracellular autophagy. Sci Rep. 13(743)2023.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ababneh NA, Al-Kurdi B, Jamali F and Awidi
A: A comparative study of the capability of MSCs isolated from
different human tissue sources to differentiate into neuronal stem
cells and dopaminergic-like cells. PeerJ. 10(e13003)2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Ababneh NA, Al-Kurdi B, Ali D, Abuarqoub
D, Barham R, Salah B and Awidi A: Establishment of a human induced
pluripotent stem cell (iPSC) line (JUCTCi010-A) from a healthy
Jordanian female skin dermal fibroblasts. Stem Cell Res.
47(101891)2020.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
|
53
|
Ababneh NA, Al-Kurdi B, Ali D, Barham R,
Sharar N, Mrahleh MM, Salah B and Awidi A: Generation of a human
induced pluripotent stem cell (iPSC) line (JUCTCi011-A) from skin
fibroblasts of a healthy Jordanian male subject. Stem Cell Res.
48(101923)2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Karam M and Abdelalim EM: Robust and
highly efficient protocol for differentiation of human pluripotent
stem cells into mesenchymal stem cells. Methods Mol Biol.
2454:257–271. 2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Sober SA, Darmani H, Alhattab D and Awidi
A: Flow cytometric characterization of cell surface markers to
differentiate between fibroblasts and mesenchymal stem cells of
different origin. Arch Med Sci. 19:1487–1496. 2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wang S, Hou Y, Li X, Song Z, Sun B, Li X
and Zhang H: Comparison of exosomes derived from induced
pluripotent stem cells and mesenchymal stem cells as therapeutic
nanoparticles for treatment of corneal epithelial defects. Aging
(Albany NY). 12:19546–19562. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Koliha N, Wiencek Y, Heider U, Jüngst C,
Kladt N, Krauthäuser S, Johnston ICD, Bosio A, Schauss A and Wild
S: A novel multiplex bead-based platform highlights the diversity
of extracellular vesicles. J Extracell Vesicles.
5(29975)2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Debacq-Chainiaux F, Erusalimsky JD,
Campisi J and Toussaint O: Protocols to detect
senescence-associated beta-galactosidase (SA-betagal) activity, a
biomarker of senescent cells in culture and in vivo. Nat Protoc.
4:1798–1806. 2009.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zeng ZL and Xie H: Mesenchymal stem
cell-derived extracellular vesicles: A possible therapeutic
strategy for orthopaedic diseases: A narrative review. Biomater
Transl. 3:175–187. 2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
He L, He T, Xing J, Zhou Q, Fan L, Liu C,
Chen Y, Wu D, Tian Z, Liu B and Rong L: Bone marrow mesenchymal
stem cell-derived exosomes protect cartilage damage and relieve
knee osteoarthritis pain in a rat model of osteoarthritis. Stem
Cell Res Ther. 11(276)2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Zhou X, Liang H, Hu X, An J, Ding S, Yu S,
Liu C, Li F and Xu Y: BMSC-derived exosomes from congenital
polydactyly tissue alleviate osteoarthritis by promoting
chondrocyte proliferation. Cell Death Discov. 6(142)2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Zhang F, Guo J, Zhang Z, Qian Y, Wang G,
Duan M, Zhao H, Yang Z and Jiang X: Mesenchymal stem cell-derived
exosome: A tumor regulator and carrier for targeted tumor therapy.
Cancer Lett. 526:29–40. 2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Jahangiri B, Khalaj-Kondori M, Asadollahi
E, Kian Saei A and Sadeghizadeh M: Dual impacts of mesenchymal stem
cell-derived exosomes on cancer cells: Unravelling complex
interactions. J Cell Commun Signal. 17:1229–1247. 2023.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Tan TT, Lai RC, Padmanabhan J, Sim WK,
Choo ABH and Lim SK: Assessment of tumorigenic potential in
mesenchymal-stem/stromal-cell-derived small extracellular vesicles
(MSC-sEV). Pharmaceuticals (Basel). 14(345)2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Heidegger S, Stritzke F, Dahl S,
Daßler-Plenker J, Joachim L, Buschmann D, Fan K, Sauer CM, Ludwig
N, Winter C, et al: Targeting nucleic acid sensors in tumor cells
to reprogram biogenesis and RNA cargo of extracellular vesicles for
T cell-mediated cancer immunotherapy. Cell Rep Med.
4(101171)2023.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop DJ and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The international society for cellular
therapy position statement. Cytotherapy. 8:315–317. 2006.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Maleki M, Ghanbarvand F, Reza Behvarz M,
Ejtemaei M and Ghadirkhomi E: Comparison of mesenchymal stem cell
markers in multiple human adult stem cells. Int J Stem Cells.
7:118–126. 2014.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Willms E, Cabañas C, Mäger I, Wood MJA and
Vader P: Extracellular vesicle heterogeneity: Subpopulations,
isolation techniques, and diverse functions in cancer progression.
Front Immunol. 9(738)2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Ekström K, Crescitelli R, Pétursson HI,
Johansson J, Lässer C and Olofsson Bagge R: Characterization of
surface markers on extracellular vesicles isolated from lymphatic
exudate from patients with breast cancer. BMC Cancer.
22(50)2022.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Varderidou-Minasian S and Lorenowicz MJ:
Mesenchymal stromal/stem cell-derived extracellular vesicles in
tissue repair: Challenges and opportunities. Theranostics.
10:5979–5997. 2020.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Yu J, Huang D, Liu H and Cai H: Optimizing
conditions of polyethylene glycol precipitation for exosomes
isolation from MSCs culture media for regenerative treatment.
Biotechnol J. 19(e202400374)2024.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Oksvold MP, Neurauter A and Pedersen KW:
Magnetic bead-based isolation of exosomes. Methods Mol Biol.
1218:465–481. 2015.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Niu Z, Pang RTK, Liu W, Li Q, Cheng R and
Yeung WSB: Polymer-based precipitation preserves biological
activities of extracellular vesicles from an endometrial cell line.
PLoS One. 12(e0186534)2017.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Simon L, Lapinte V and Morille M:
Exploring the role of polymers to overcome ongoing challenges in
the field of extracellular vesicles. J Extracell Vesicles.
12(e12386)2023.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Schulz-Siegmund M and Aigner A: Nucleic
acid delivery with extracellular vesicles. Adv Drug Deliv Rev.
173:89–111. 2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Li L, Tian H, Chen Z, Yue W, Li S and Li
W: Inhibition of lung cancer cell proliferation mediated by human
mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai).
43:143–148. 2011.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Wu T, Tian Q, Liu R, Xu K, Shi S, Zhang X,
Gao L, Yin X, Xu S and Wang P: Inhibitory role of bone marrow
mesenchymal stem cells-derived exosome in non-small-cell lung
cancer: microRNA-30b-5p, EZH2 and PI3K/AKT pathway. J Cell Mol Med.
27:3526–3538. 2023.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Chen R, Liu X and Tan N: Bone marrow
mesenchymal stem cell (BMSC)-derived exosomes regulates growth of
breast cancer cells mediated by hedgehog signaling pathway. J
Biomater Tissue Eng. 13:157–161. 2023.
|
|
79
|
Hu Y, Liu H, Xiao X, Yu Q, Deng R, Hua L,
Wang J and Wang X: Bone marrow mesenchymal stem cell-derived
exosomes inhibit triple-negative breast cancer cell stemness and
metastasis via an ALKBH5-dependent mechanism. Cancers (Basel).
14(6059)2022.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Liu H, Dilger JP and Lin J: Effects of
local anesthetics on cancer cells. Pharmacol Ther.
212(107558)2020.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Maretzky T, Evers A, Zhou W, Swendeman SL,
Wong PM, Rafii S, Reiss K and Blobel CP: Migration of growth
factor-stimulated epithelial and endothelial cells depends on EGFR
transactivation by ADAM17. Nat Commun. 2(229)2011.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Yan M, Yang X, Shen R, Wu C, Wang H, Ye Q,
Yang P, Zhang L, Chen M, Wan B, et al: miR-146b promotes cell
proliferation and increases chemosensitivity, but attenuates cell
migration and invasion via FBXL10 in ovarian cancer. Cell Death
Dis. 9(1123)2018.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Svensson S, Nilsson K, Ringberg A and
Landberg G: Invade or proliferate? Two contrasting events in
malignant behavior governed by p16(INK4a) and an intact Rb pathway
illustrated by a model system of basal cell carcinoma. Cancer Res.
63:1737–1742. 2003.PubMed/NCBI
|
|
84
|
Evdokimova V, Tognon C, Ng T and Sorensen
PH: Reduced proliferation and enhanced migration: Two sides of the
same coin? Molecular mechanisms of metastatic progression by YB-1.
Cell Cycle. 8:2901–2906. 2009.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Ou HL, Hoffmann R, González-López C,
Doherty GJ, Korkola JE and Muñoz-Espín D: Cellular senescence in
cancer: From mechanisms to detection. Mol Oncol. 15:2634–2671.
2021.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Calcinotto A, Kohli J, Zagato E,
Pellegrini L, Demaria M and Alimonti A: Cellular senescence: Aging,
cancer, and injury. Physiol Rev. 99:1047–1078. 2019.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Domen A, Deben C, Verswyvel J, Flieswasser
T, Prenen H, Peeters M, Lardon F and Wouters A: Cellular senescence
in cancer: Clinical detection and prognostic implications. J Exp
Clin Cancer Res. 41(360)2022.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Yaghoubi Y, Movassaghpour A, Zamani M,
Talebi M, Mehdizadeh A and Yousefi M: Human umbilical cord
mesenchymal stem cells derived-exosomes in diseases treatment. Life
Sci. 233(116733)2019.PubMed/NCBI View Article : Google Scholar
|
